Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Male hormones worsen kidney transplant damage, but blocking them helps.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Both drugs lower DHT levels, with GI198745 being more effective.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

AMT may cause hair loss and changing dWAT activity could help treat it.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Women with acne have lower levels of a specific hormone marker than women without acne.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Some flavonoids may help with hair growth by affecting blood vessel function in hair follicles.